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Abstract
Background: Major depression, although frequent in primary care, is commonly hidden behind multiple physical
complaints that are often the first and only reason for patient consultation. Major depression can be screened by two
validated questions that are easier to use in primary care than the full Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (DSM-IV) criteria. A third question, called the ‘help’ question, improves the specificity without
apparently decreasing the sensitivity of this screening procedure. We validated the abbreviated screening procedure for
major depression with and without the ‘help’ question in primary care patients managed for a physical complaint.
Methods: This diagnostic accuracy study used data from the SODA (for ‘SOmatisation Depression Anxiety’) cohort
study conducted by 24 general practitioners (GPs) in western Switzerland that included patients over 18 years of age
with at least a single physical complaint at index consultation. Major depression was identified with the full Patient
Health Questionnaire. GPs were asked to screen patients for major depression with the three screening questions
1 year after inclusion.
Results: Of 937 patients with at least a single physical complaint, 751 were eligible 1 year after index consultation.
Major depression was diagnosed in 69/724 (9.5%) patients. The sensitivity and specificity of the two-question method
alone were 91.3% (95% CI 81.4 to 96.4) and 65.0% (95% CI 61.2 to 68.6), respectively. Adding the ‘help’ question
decreased the sensitivity (59.4%; 95% CI 47.0 to 70.9) but improved the specificity (88.2%; 95% CI 85.4 to 90.5) of the
three-question method.
Conclusions: The use of two screening questions for major depression was associated with high sensitivity and
low specificity in primary care patients presenting a physical complaint. Adding the ‘help’ question improved the
specificity but clearly decreased the sensitivity; when using the ‘help’ question, four out of ten patients with
depression will be missed, compared to only one out of ten with the two-question method. Therefore, the ‘help’
question is not useful as a screening question, but may help discussing management strategies.
Background
Major depression is found in 3.9% of the general popula-
tion in Europe [1] and a prevalence of 5% to 14% has
been reported in primary care patients [2-6]. In a more
recent meta-analysis the rate of depression was even of
17% to 19% [7]. However, major depression is commonly
hidden behind multiple and sometimes unexplained phy-
sical complaints that are often the first and only reason
for patients to request consultation [8-12]. Detecting
mental disorders in the presence of such complaints is
thus an important challenge for general practitioners
(GPs) [13]. To help GPs detect major depression, a
screening tool containing two questions has been derived
from the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (DSM-IV) criteria and validated
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[14]. These questions are simple, respectful, easy to inte-
grate into the consultation, and require less time than the
full DSM-IV criteria. Arroll et al. [15,16] suggested the
addition of a third question called the ‘help’ question, in
which the patient is asked whether they would like help
regarding the issues raised by the first two screening
questions. This new screening tool was reported to result
in increased specificity (from 67% to 89%) not accompa-
nied by decreased sensitivity (from 97% to 96%). In gen-
eral, the addition of a mandatory qualifying question to a
screening tool usually decreases the sensitivity and
increases the specificity of the test, unless the added
question is perfectly discriminatory.
Since most primary care patients are usually followed by
their GP for many years, we conducted a novel investiga-
tion into the utility of these screening procedures over
time. We examined the contribution to diagnosis of the
two screening questions and the additional ‘help’ question
in patients previously seen by a GP for a physical com-
plaint (index consultation) and followed-up for a year. The
accuracies of the two-question and three-question screen-
ing methods were explored across subgroups defined by
age, gender, education level, migration status, presence of
other mental disorders (anxiety, somatoform disorder,
alcohol abuse), and presentation of major or minor
depression at the time of index consultation.
Methods
This diagnostic accuracy study was nested within a larger
cohort study on the occurrence and correlations of depres-
sion, anxiety, and somatoform disorders (the SODA (for
‘SOmatisation Depression Anxiety’) cohort study [17]) in
primary care patients with physical complaints who were
followed over 1 year. Data were collected in western
French-speaking Switzerland by 21 GPs in private practice
and 3 medical doctor (MD) trainees from 1 academic pri-
mary care centre from November 2004 to March 2007.
This study protocol was approved by the State Ethics
Committee of the Canton of Vaud (Prot.100/04).
Patients and follow-up
This study, conducted 1 year after the index consultation,
included consenting patients aged 18 years and over who
presented with at least 1 physical complaint during the
index consultation at 1 of 22 recruiting centres. Patients
with vital emergencies, dementia, intellectual deficiency,
inability to understand French, or acute psychiatric dis-
eases that prevented the patient from answering appropri-
ately were excluded. The GPs included one patient per
each half-day of consultation. To minimise selection bias,
patients eligible for inclusion were selected by each GP
using a pre-established, daily, randomised rank order list,
thus defining each eligible patient for every half-day. In
the academic primary care centre all eligible patients were
enrolled (MD trainees see fewer patients) nevertheless
more patients could not be included, mainly due to lan-
guage barriers. GPs completed a case report form for each
patient. Each patient received a self-administered ques-
tionnaire that was either to be completed in the waiting
room or returned by mail in the next few days. Patients
were followed-up by their GPs as needed according to
usual practice. The 1-year follow-up consultation took
place during a scheduled visit 9-15 months after the index
consultation. Patients who did not consult their physicians
spontaneously during the 1-year follow-up were invited by
phone to plan a visit within the next 3 months. Data col-
lected during the follow-up consultation allowed the
assessment of the accuracy of the screening questions in
detecting major depression.
The participating primary care physicians were all
trained in family practice or general internal medicine and
worked in primary care settings. These physicians were
trained in the use of the three screening questions for
major depression. GPs were allowed to investigate depres-
sion only after they asked the three screening questions.
Physicians were blinded to the reference standard results
of both the initial and follow-up consultations, but were
not necessarily blinded to the patient’s depression status.
Questionnaires
During the index and follow-up consultations, GPs read
out the two screening questions for major depression:
‘During the past month have you often been bothered by
feeling down, depressed, or hopeless?’ and ‘During the
past month have you often been bothered by little interest
or pleasure in doing things?’. Patients responding posi-
tively to either of these questions were asked the ‘help’
question: ‘Is this something with which you would like
help?’ with three possible responses: ‘no’, ‘yes, but not
today’, or ‘yes’. These three screening questions were
translated from English to French and then reverse trans-
lated. Patients responding positively to either of the first
two questions were considered ‘positive’ for the two
screening questions. Patients who responded positively to
either of the two questions and to the ‘help’ question (’yes’
or ‘yes, but not today’) were considered ‘positive’ for the
three screening questions. All other patients were consid-
ered ‘negative’.
After the consultation, the patients independently com-
pleted the reference standard questionnaire (full Patient
Health Questionnaire (PHQ)) [3,18,19], a validated French
version of the self-reported Primary Care Evaluation of
Mental Disorders (PRIME-MD) [20] questionnaire. This
questionnaire was designed to detect mental disorders in
primary care practice, including depression, anxiety, alco-
hol abuse, and eating and somatoform disorders. To clas-
sify whether patients had major depression, we used nine
questions corresponding to DSM-IV criteria (questions 2a
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to 2i) [18]. Patients who responded positively to at least
one of the first two screening questions and to five or
more of the nine questions were considered to have major
depressive syndrome. Minor depression was considered
present when three or four of the nine questions were
answered positively and at least one of the two core
questions.
Anxiety, somatoform disorder, alcohol abuse and expo-
sure to psychosocial stressors were assessed with PHQ
questions. Patients were considered to be exposed to a
psychosocial stressor if they reported being bothered a lot
by at least one of the ten stressors assessed with question
12 of the full PHQ [18] (1, health; 2, weight or appearance;
3, having little or no sexual desire or pleasure during sex;
4, difficulties with husband/wife, partner/lover or boy-
friend/girlfriend; 5, the stress of taking care of children,
parents or other family members; 6, stress at work or out-
side of the home or at school; 7, financial problems or
worries; 8, having no one to turn to when having a pro-
blem; 9, something bad that happened recently; 10, think-
ing or dreaming about something terrible that happened
in the past). Sociodemographic questions included age,
gender, and nationality (dichotomised into Swiss or non-
Swiss). Professional education included eight categories
summarised in a dichotomised variable: presence or
absence of fully achieved training beyond compulsory
school.
Questionnaires were sent to the data centre, and all vari-
ables were double entered and checked. A researcher,
blinded to index consultation results, determined which
patients presented PHQ criteria for major depression.
Statistical methods
The sample size necessary to obtain a 10%-wide interval
around a 70% expected sensitivity (a = 0.05) was calcu-
lated, assuming a 10% prevalence of major depression.
The expectation of 20% loss to follow-up led to a total of
947 patients required for inclusion, a figure that was
rounded to 1,000 patients.
Sensitivity, specificity, positive and negative likelihoods,
and predictive values were calculated, with their respective
95% confidence intervals (95% CIs), to determine screen-
ing test accuracy. Sensitivity, specificity, and 95% CIs were
also calculated for subpopulations stratified by age, gender,
nationality, education level, anxiety, somatoform disorder,
depression status at the index consultation, and exposure
to a psychosocial stressor. Although these variables were
predefined before analysis, this study was not sufficiently
powerful to detect significant clinical differences between
subgroups. The effects of these factors on the screening
method were estimated by likelihood ratio test comparing
logistic regression models with or without an interaction
term. Characteristics of the patients (age, gender, level of
education, and depression at index consultation) were
compared between patients included and those excluded
from the analysis to assess potential selection bias.
Results
Between November 2004 and July 2005, 937 patients
were included in the present study. At 1 year after inclu-
sion, 751 patients agreed to be questioned (Figure 1). A
total of 12 patients did not answer all PHQ questions,
making it impossible to know whether they were suffer-
ing from depression, and the physician did not report the
results of 3 screening questions for 15 other patients.
Thus, 724 patients were included in the analysis. The
included patients were similar to those excluded regard-
ing gender (63.3% of women in the group included vs
62.4%), age of 65 years or over (29.8% vs 25.3%), educa-
tion level (79.9% vs 79.8%), and presence of major
depression at the index consultation (11.3% vs 14.0%).
Most patients (91.3%) were recruited from private prac-
tices, with the number of patients from each practice ran-
ging from 6 to 58. Patients were mainly women (63.3%)
and had a mean age of 54.7 years (SD 17 years). The
most frequent diagnoses for the main physical complaint
were musculoskeletal (29.9%) or digestive (8.4%). In 94
patients (13%), a mental disorder was considered to be
related to the initial physical complaint. During the year
of follow-up, 83.1% of patients visited their GP at least
once, and 40.4% received psychotherapeutic care from
their GP. Psychotropic drugs were used by 34.2% of the
patients and 8.1% were referred to either a psychiatrist or
a psychologist. At 1 year after the index consultation the
prevalence of major depression was of 9.5%.
The depression screening test administered by GPs
was completed on the same day as the reference test
(PHQ) by 59.3% and within 1 week by additional 25% of
patients. Physicians did not report any adverse effects of
using the three screening questions. GPs did not report
an answer to the ‘help’ question in five patients (0.7%).
The sensitivity and specificity of the two screening
questions were 91.3% (95% CI 81.4 to 96.4) and 65.0%
(95% CI 61.2 to 68.6), respectively (Table 1). Adding the
‘help’ question improved the specificity to 88.2% (95% CI
85.4 to 90.5), but the sensitivity decreased to 59.4% (95%
CI 47.0 to 70.9). In fact, 118 (40.4%) of the patients initi-
ally screened positive for depression (N 292) were willing
to accept help (Figure 2). Considering the patients who
were not already being treated for major depression only,
the sensitivity and the specificity of the two-question
method are, respectively, 84.6% (95% CI 54.6 to 98.1) and
76.8% (95% CI 72.0 to 81.2). For the three-question
method the sensitivity decreased to 46.2% (95% CI 19.2
to 74.9) and the specificity increased to 94.5% (95% CI
91.5 to 96.7).
We next explored the sensitivity and specificity of both
screening instruments in various patient subpopulations
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(Table 2). The sensitivity of the two-question method was
high and consistent through the entire population, ran-
ging from 80% (95% CI 51.3 to 94.6) in patients older
than 65 years to 100% (95% CI 83.4 to 100) in men. The
specificity of both screening instruments exhibited
important disparities across patients with various mental
states. Patients who suffered from depression at the
index consultation, who were exposed to a psychosocial
Eligible patients
N=1020
Refused to participate
N=83
Consent to participate
N=937
Follow-up patients at one 
year
N=751
Patients with data 
completed enough for 
our analysis
N=724
Lost at follow-up N=186
• 10 patients died
• 44 of them were unreachable
• 31 CRFs were not completed 
by  physicians without any 
given explanation 
• 17 refused to answer 
questions at one year
• 84 Questionnaire was not 
returned by  the patient
Missing data N=27
• 1 Missing questionnaire  from 
the GP
• 12  patients with missing data 
for the diagnostic of depresion 
• 14  no response were given 
about the screening questions 
Figure 1 Flowchart of eligible patients.
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stressor during the 4 previous weeks, or who were diag-
nosed with either anxiety or somatoform disorder were
more likely to answer positively to each screening instru-
ment without being diagnosed as having depression, as
indicated by a lower specificity (Table 2).
Discussion
In primary care patients well known by their GPs, the
two-question screening method for major depression dis-
played high sensitivity (91%) and low specificity (65%). As
suspected, adding the ‘help’ question led to a decreased
sensitivity (59%) but a higher specificity (88%). We also
observed a lower specificity for the two-question and
three-question methods in subpopulations with other
psychiatric conditions (such as generalised anxiety) and
in patients who had exhibited major depression 1 year
previously.
The strengths of our study are its large sample size, the
number and diversity of the participating GPs, and the
use of standardised, validated measures for mental disor-
ders. Furthermore, the random selection of patients and
their recruitment from a large number of GPs in various
settings decreased the risk of selection bias. We therefore
believe that our observations are relevant for most
patients with physical complaints in primary care in
developed countries. However, our study is limited
because the two screening questions for major depression
were similar to those of the PHQ-9, our reference stan-
dard. Therefore, the sensitivity of the screening method
is expected to be very high. Finally, the PHQ-9 may not
be the best reference standard for major depression for
the following three reasons: (1) it is self-report, (2) it
doesn’t apply exclusion criteria, and (3) it doesn’t apply
clinical significance criteria. Thus PHQ-9 can only be
interpreted as a proxy of DSM-IV [21,22]. Therefore a
standardised visit to a psychiatrist would have been
preferred.
Whooley et al. [23] and Arroll et al. [24] first intro-
duced the two-question screening method and reported
high sensitivities (96% and 97%, respectively) and low
specificities (57% and 67%, respectively). Löwe et al. [25]
evaluated the two screening questions in outpatients and
obtained similar results with a dichotomous answer (yes/
no). Furthermore, the two-question method was able to
detect changes in a patient’s state of depression. Here we
report observations similar to those of Arroll et al. [24]
regarding screening for major depression with two ques-
tions. The high sensitivity of these questions allows GPs
to securely rule out negative patients, but the relatively
low specificity requires further investigations to confi-
dently diagnose major depression in positive cases [14].
Introduction of the third ‘help’ question was a very
interesting and logical proposition, and should have
facilitated the diagnosis of major depression. When we
added the ‘help’ question to the screening method, how-
ever, our observations were substantially different from
those of Arroll et al., [15] who reported increased specifi-
city (89%) but identical sensitivity (96%). As an important
number of their patients with major depression
responded ‘no’ to the ‘help’ question, it is not clear why
the sensitivity remained identical. In a second study,
Goodyear et al. [16] validated the two-question and
three-question methods using the PHQ-9 as a reference
standard for major depression. Although the two-ques-
tion method was associated with a sensitivity of 98% and
a specificity of 73%, and the specificity of the three-ques-
tion method questions was reported to be 99%, the sensi-
tivity of the three-question method was not provided.
A recent publication by the same authors determines a
sensitivity of 99.2% and a specificity of 70.4% for the two-
question method, whereas the sensitivity decreased to
87.1% and the specificity increased to 94.8% for the
three-question method [26].
An independent study by Baker-Glenn et al. [27]
observed a sensitivity of 23.7% and specificity 97.8% in
patients attending chemotherapy with the three-question
method. We therefore believe Arrol et al.’s [15] results
to be misleading. These findings support the latest
NICE [28] guidelines that recommend only the use of
the two screening questions.
Table 1 Sensitivity, specificity, positive/negative predictive values, positive/negative likelihood ratios for major
depression
Parameter Two screening questions
% (95% CI)
Three screening questions
% (95% CI)
Sensitivity 91.3% (81.4 to 96.4) 59.4% (47.0 to 70.9)
Specificity 65.0% (61.2 to 68.6) 88.2% (85.4 to 90.5)
Positive predictive value 21.6% (17.1 to 26.8) 34.7% (26.4 to 44.1)
Negative predictive value 98.6% (96.8 to 99.4) 95.3% (93.3 to 96.8)
Positive likelihood ratio 2.6 (2.3 to 3.0) 5.0 (3.8 to 6.7)
Negative likelihood ratio 0.1 (0.06 to 0.28) 0.5 (0.3 to 0.6)
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Our analysis indicates that although the three-ques-
tion method has high negative predictive value, the high
false negative rate implies that as many as four patients
out of ten (28/69) with major depression would not be
correctly diagnosed with this method. In comparison,
less than one out of ten patients (6/69) with major
depression will not be diagnosed when using the two-
question method. It is therefore not helpful to include
Patients with
physical complaint
N=724
«N
o»
 to
 bo
th 
sc
re
en
ing
 qu
es
tio
ns « Yes » to at least one 
of the screening questions
Negative to the 
two-screening questions
n= 432
Positive to the 
two-screening questions
n= 292
n %
Major depression 6 1.4%
Minor depression 10 2.3%
No depression 416 96.3%
Negative to the 
three-screening questions
n= 606
Negative to the 
Help question
n= 174
Positive to the 
three-screening questions
n= 118
« Yes » 
to the help question
« No » 
to the help question
n %
Major depression 28 4.6%
Minor depression 41 6.8%
No depression 537 88.6%
n %
Major depression 63 21.6%
Minor depression 47 16.1%
No depression 182 62.3%
n %
Major depression 41 34.7%
Minor depression 16 13.6%
No depression 61 51.7%
Figure 2 Flowchart of screening.
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the third ‘help’ question to rule out major depression in
patients well known by their GPs. But as Kroenke [29]
suggests, ‘screening for depression is not enough’.
Patients identified with depression have to be treated.
Therefore the ‘help’ question remains clinically relevant,
even if more than half of patients with major depression
did not ask for help. But within the context of the con-
sultation, the ‘help’ question enables a continuing dis-
cussion about mood disorders and allows evaluation of
the appropriateness of a psychiatric treatment and refer-
ral. Baker-Glenn et al. conclude, as we do, that the
‘help’ question may highlight patients willing to accept
support [27]. This also underlines GPs’ role in investi-
gating and answering patient expectations for their psy-
chological distress as described by Walters showing that
patients with milder symptoms usually prefer simple
human contact, and informal resource rather than for-
mal interventions or medication [30]. While all these
questions may help GPs screen for major depression in
their patients, this tool should not replace clinical
judgment; indeed, GPs seldom rely on questionnaires
alone [31,32].
Our observations suggest that the sensitivity of the two
screening questions is consistent across various patient
subpopulations guaranteeing a low number of false nega-
tives regardless of patient characteristics. However, as the
specificity differs across patients, GPs may frequently and
falsely diagnose major depression in patients who present
other mental disorders. Additional studies are necessary to
quantify the actual benefits of screening mental disorders
in primary care with the two-question and three-question
screening methods.
Conclusions
The two-question screening method for major depression
exhibited a high sensitivity and a low specificity when
applied to well known primary care patients with a physi-
cal complaint. Adding the ‘help’ question improved the
specificity of the test, but clearly decreased its sensitivity:
four out of ten patients will thus be missed with the
Table 2 Stratified specificity of screening questions for major depression
Characteristic Prevalence of
depression,
% (95% CI)
Specificity, % (95% CI)
Two screening
questions
Three screening
questions
Overall 9.5% (7.6 to 12.0) 65.0% (61.2 to 68.6) 88.2% (85.4 to 90.5)
Gender
Male 9.4% (6.3 to 13.7) 69.2% (63.0 to 75.0) 90.0% (85.4 to 93.4)
Female 9.6% (7.1 to 12.8) 62.5% (57.7 to 67.2) 87.2% (83.5 to 90.2)
Age
< 65 years 10.9% (8.4 to 14.1) 66.1% (61.4 to 70.5) 87.4% (83.8 to 90.3)
≥ 65 years 6.4% (3.8 to 10.6) 62.8% (56.0 to 69.2) 89.9% (84.9 to 93.4)
Nationality
Swiss 8.0% (6.0 to 10.6) 67.6% (63.3 to 71.5) 89.1% (86.0 to 91.5)
Not Swiss 14.8% (9.4 to 22.5) 53.2% (43.4 to 62.7) 84.4% (75.9 to 90.4)
Education level
Professional training 9.4% (71.5 to 12.3) 66.8% (62.4 to 70.9) 88.3% (85.1 to 91.0)
No professional training 9.0% (5.0 to 15.1) 60.6% (51.7 to 68.8) 88.6% (81.7 to 93.3)
Psychosocial stressors
≥ 1 major stressor 21.5% (16.9 to 26.9) 44.3% (37.6 to 51.1) 77.6% (71.4 to 82.8)
No major stressor 2.0% (1.0 to 4.0) 76.0% (71.7 to 79.9) 93.7% (90.9 to 95.7)
Mood disorders 1 year previously
Major depression 39.0% (28.6 to 50.4) 34.0% (21.6 to 48.8) 62.0% (47.1 to 75.0)
Minor depression 15.0% (7.5 to 27.1) 43.1% (29.6 to 57.7) 84.3% (70.8 to 92.5)
No depression 39.1% (25.2 to 59.5) 70.1% (66.0 to 73.9) 91.1% (88.3 to 93.3)
Anxiety
Anxiety syndrome 60.0% (45.2 to 73.2) 5% (0.2 to 26.9) 40.0% (20.0 to 63.6)
No anxiety 57.1% (41.2 to 78.3) 67.1% (63.3 to 70.8) 89.8% (87.1 to 92.0)
Somatoform disorder
≥ 3 symptoms 31.7% (22.1 to 43.0) 46.4% (33.2 to 60.1) 67.9% (53.9 to 79.4)
< 3 symptoms 6.7% (5.0 to 9.0) 67.7% (62.7 to 70.4) 90.1% (87.4 to 92.3)
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three-question method, compared to only one out of ten
with the two-question method. Although the ‘help’ ques-
tion is not useful as a screening question in this patient
group, it may facilitate discussion about mood disorders
and its management.
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